Skip to content

Zosano Pharma Corp

CIK 0001587221

← back to feed
Revenue (TTM)
$830K
+250.4% YoY Q1 May 2022
Net Income (TTM)
−$56.36M
+10.3% YoY Q1 May 2022
EPS Diluted (TTM)
−$10.72
+44.9% YoY Q1 May 2022
Gross Margin
4.8%
Q1 May 2022
Operating Margin
-6,979.9%
Q1 May 2022
Net Margin
-6,790.7%
Q1 May 2022
Free Cash Flow (TTM)
−$40.61M
Q1 May 2022
Cash
$13.53M
Q1 May 2022
Total Debt
$0
Q1 May 2022
Shares Outstanding
4.9M sh
Q1 May 2022

Revenue & Net Income

EPS (Diluted)

Margins

Cash Flow

Revenue Growth (YoY)

Balance Sheet

Cash vs Debt

Recent filings